Physician profile
Bharathi Raju
NPI 1720078843
$23,886.29
in general payments reported to CMS, 2019-2025
63 companies · $1,763 in 2025
The $1,763 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,088 · 2020: $6,407 · 2021: $4,382 · 2022: $1,805 · 2023: $2,413 · 2024: $2,028 · 2025: $1,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,203.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $6,323.74 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $2,762.43 | 2019-2025 | Omnipod |
| Novo Nordisk INC | $2,063.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $1,617.51 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Lilly USA, LLC | $1,309.28 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $919.62 | 2019-2025 | Repatha, Tepezza, Repatha |
| Mannkind Corporation | $893.50 | 2019-2025 | Afrezza |
| Amarin Pharma, INC. | $524.07 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.73 | 2019-2025 | Jardiance |
| Antares Pharma, INC. | $459.51 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $452.61 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $435.39 | 2019-2025 | |
| Nevro Corp. | $366.88 | 2022-2024 | Senza |
| Ibsa Pharma INC. | $322.70 | 2020-2025 | Tirosint, Licart, Licart |
| Novartis Pharmaceuticals Corporation | $312.68 | 2022-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $309.55 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $297.90 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $293.73 | 2021-2025 | Isturisa, Signifor Lar |
| Corcept Therapeutics | $272.23 | 2020-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $262.85 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Esperion Therapeutics, INC. | $245.92 | 2020-2025 | Nexletol |
| Dexcom, INC. | $178.83 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $172.16 | 2019-2020 | |
| Abbvie INC. | $166.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $147.83 | 2019-2022 | |
| Beta Bionics, INC. | $145.84 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Clarus Therapeutics INC. | $142.65 | 2021 | |
| Radius Health, INC. | $135.53 | 2019-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $132.98 | 2020-2025 | Unithroid |
| Medtronic, INC. | $129.74 | 2022-2025 | Vanta Adaptivestim, Inceptiv, Minimed 780g |
| Madrigal Pharmaceuticals | $124.27 | 2024-2025 | Rezdiffra, Resmetirom |
| Amphastar Pharmaceuticals, INC. | $119.03 | 2023-2025 | Baqsimi |
| Janssen Pharmaceuticals, INC | $114.25 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $95.40 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.96 | 2019-2020 | |
| Lifescan, INC. | $90.41 | 2019-2023 | |
| Pfizer INC. | $85.37 | 2019-2025 | |
| Companion Medical, INC. | $84.98 | 2019 | |
| Sequel Med Tech, LLC | $80.66 | 2024-2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $74.96 | 2024-2025 | Yorvipath |
| Acella Pharmaceuticals, LLC | $72.14 | 2023-2025 | NP Thyroid 60 |
| Verity Pharmaceuticals INC. | $69.31 | 2025 | Tlando |
| Globus Medical, INC. | $57.96 | 2025 | Senza |
| Valeritas, INC. | $56.71 | 2019 | |
| Optos, INC. | $44.92 | 2020-2021 | |
| Echosens North America, INC. | $38.48 | 2024-2025 | Fibroscan, Fibroscan |
| Itamar Medical INC | $34.67 | 2025 | Watchpatone |
| Averitas Pharma INC. | $33.62 | 2023 | Qutenza |
| Sandoz INC. | $30.57 | 2025 | Jubbonti |
| Senseonics, Incorporated | $29.00 | 2019 | |
| Kyowa Kirin, INC. | $22.01 | 2025 | |
| Embecta Corp. | $21.03 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Halozyme INC | $20.34 | 2023 | |
| Rhythm Pharmaceuticals, INC. | $19.34 | 2024 | Imcivree |
| Currax Pharmaceuticals LLC | $16.58 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.74 | 2020 | |
| Zealand Pharma US, INC. | $13.95 | 2021 | |
| Topcon Healthcare Solutions, INC. | $13.90 | 2020 | |
| Amryt Pharma Holdings LTD | $13.57 | 2021 | |
| Shire North American Group INC | $13.50 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.90 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharathi Raju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.